The New Jersey Cannabis Regulatory Commission is a state government agency that regulates the sale of medicinal and recreational marijuana products in New Jersey. [1]
The New Jersey Cannabis Regulatory Commission was created through the enactment of the Jake Honig Compassionate Use Medical Cannabis Act, signed by Governor Phil Murphy on July 2, 2019. [2]
The Commission, "in but not of the Department of the Treasury," was granted responsibility over the state's medical marijuana program. [3]
The Commission has five members, all appointed by the governor. Commissioner Krista Nash, [1] was named upon the recommendation of the Senate President and Commissioner Samuel Delgado [1] from the House Speaker's recommendation. [2]
In 2022, the Commission was led by its Chair, Dianna Houenou. [1] Houenou was appointed to the position in 2021 by Governor Murphy. Previously, she worked as an advisor to Murphy and as an attorney with the New Jersey American Civil Liberties Union (ACLU). She earned her BA in Chemistry and Afro-American Studies from the University of North Carolina at Chapel Hill and her JD from the University of North Carolina School of Law. [1]
On the staff side, the commission is headed by Executive Director Jeff Brown, a former state lobbyist. [4] Brown oversees the offices and staff of the Commission. [5] He has defended the commission's slow implementation of the state's recreational marijuana law. [6]
New Jersey's original medical marijuana program began through legislation known as Compassionate Use of Medical Marijuana Act (CUMMA). [7] It was later updated and patient access was expanded when the New Jersey Jake Honig Compassionate Use Medical Cannabis Act was implemented. [8] Under current law, medical marijuana patients are allowed to access up to three ounces of marijuana from state-approved and regulated dispensaries every 30 days. [8]
Prior to the passage of the Jake Honig Compassionate Use Medical Cannabis Act, medical marijuana was legal in New Jersey under the Medicinal Marijuana Program (MMP). The Honig Act updated and reformed the program, and created the New Jersey Cannabis Regulatory Commission. (In 2019, when this Act was signed into law, the state had not yet approved the sale of recreational marijuana). Prior to the law, the program was run by the Division of Medicinal Marijuana at the New Jersey Department of Health. [3]
The Jake Honig Act also lifted the ceiling on marijuana amounts for terminally ill patients, allowing them unlimited access to the product. [3]
Cannabis was legalized by 2020 New Jersey Public Question 1 which amended the Constitution of New Jersey. In February 2021, the state legislature passed and the governor signed the Cannabis Regulatory, Enforcement Assistance, and Marketplace Modernization (CREAMM) Act which regulated the sale and possession of cannabis for adults 21 and over in New Jersey. [9]
In March 2020, the New Jersey Supreme Court ruled that people who are medical cannabis patients cannot be fired from their jobs for testing positive for marijuana if their usage is done off-duty. The case stemmed from a funeral director who was suffering from cancer and was a medical cannabis patient. He was in a car collision while working, and the follow-up drug test showed positive for cannabis. Even though he used the product legally while at home as treatment for his cancer, he was fired. The New Jersey Attorney General's Office supported the high court's ruling. [10]
New Jersey citizens voted for the legalization of adult recreational marijuana use in November 2020. The law was supposed to go into effect over a year later on February 20, 2022, although it was delayed. According to Financial Regulation News, the state "ignored the date, saying it was too early." [6]
Executive Director Jeff Brown defended the state's sluggish implementation, saying, "Since the portal opened in December, potential cannabis entrepreneurs have been establishing accounts and beginning the application process, so we did not see the flurry of new accounts being set up today as we did on December 15." [6]
Since passage of the recreational law, the commission has had a backlog of applications from medical cannabis companies. In April 2022, at the urging of the legislature, the commission held a special meeting to expedite approval of applications, although enough licenses still were not granted. The commission admitted that there is going to be a large gap between supply and demand (roughly 116,000-208,000 pounds of medical cannabis short of expected demand). Over a dozen cannabis companies applying for licenses sued the commission. [11]
A New Jersey Appellate Division court reviewed a case brought by medical cannabis businesses that had applied for applications, in a case filed against the Commission. The appeals court sent the businesses back to the commission so that the companies could have a chance to show the commission where they had made mistakes. In its 75-page ruling, the court also warned the commission that it needed to give the companies the licenses they had applied for.
In a twist, 14 months after the ruling, the commission dug in its heels, issuing "a new round of denials." They opposed the findings of the court and defended their own actions. In the end, they defied the court and refused to change the scores they gave to the applications. [11]
In January 2022, U.S. Rep. Donald Payne (D-NJ) criticized the Commission, saying in a press release that he was "outraged to hear that Black-owned businesses have been shut out of the state's cannabis marketplace." African American Chamber of Commerce of New Jersey President John Harmon joined in the criticism, saying that out of the 56 licenses awarded to date, none had been awarded to a black-owned business. Governor Phil Murphy's office defended the program and replied that applications had indeed gone to minority-owned businesses. [12]
In February 2022, the Commission tweeted an image celebrating Black History Month. According to digital news site NJ.com, "It didn't go over well. The comments section was immediately barraged by a host of people asking one fundamental question: How many Black people had been licensed to grow and sell weed?" [13]
The Commission "refused" to release data on minority licenses, according to NJ.com. However, "During the course of reporting on this story, one Black female medical cannabis dispensary awardee, Suzan Nickelson of Holistic Solutions, has come forward." [5]
In 2022, the commission faced a discrimination lawsuit that "alleges fraud in the diversity certifications it uses to score license applicants". [13]
Due to the commission being slow to issue cannabis licenses, several companies proceeded with cannabis sales despite not having licenses in a process known as the "gifting loophole." The loophole takes advantage of the law's decriminalization of possession and sale of a small amount of cannabis, effectively making unlicensed sales of cannabis not punishable by any criminal penalty. However, civil penalties could arise. [14] [15]
Proposition 215, or the Compassionate Use Act of 1996, is a California law permitting the use of medical cannabis despite marijuana's lack of the normal Food and Drug Administration testing for safety and efficacy. It was enacted, on November 5, 1996, by means of the initiative process, and passed with 5,382,915 (55.6%) votes in favor and 4,301,960 (44.4%) against.
In the United States, the removal of cannabis from Schedule I of the Controlled Substances Act is a proposed legal and administrative change in cannabis-related law at the federal level. It has been proposed repeatedly since 1972. The category is the most tightly restricted category reserved for drugs that have "no currently accepted medical use.”
The Oregon Liquor and Cannabis Commission (OLCC), formerly known as Oregon Liquor Control Commission is a government agency of the U.S. state of Oregon. The OLCC was created by an act of the Oregon Legislative Assembly in 1933, days after the repeal of prohibition, as a means of providing control over the distribution, sales and consumption of alcoholic beverages. To this end, the agency was given the authority to regulate and license those who manufacture, sell or serve alcohol. Oregon is one of 18 alcoholic beverage control states that directly control the sales of alcoholic beverages in the United States. In 2014, the passage of Oregon Ballot Measure 91 (2014) legalized the recreational use of marijuana in Oregon and gave regulatory authority to the OLCC.
In the United States, increased restrictions and labeling of cannabis as a poison began in many states from 1906 onward, and outright prohibitions began in the 1920s. By the mid-1930s cannabis was regulated as a drug in every state, including 35 states that adopted the Uniform State Narcotic Drug Act. The first national regulation was the Marihuana Tax Act of 1937.
The New Jersey Department of Health (NJDOH) is a governmental agency of the U.S. state of New Jersey. New Jersey's State Board of Health was established in 1877. Its administrative functions were vested in the Department of Health, which was created in 1947. In 1996, the latter was renamed the Department of Health and Senior Services (DHSS). In 2012, senior services programs moved back into the Department of Human Services, and DHSS again became the Department of Health.
Cannabis in Oregon is legal for both medical and recreational use. In recent decades, the U.S. state of Oregon has had a number of legislative, legal, and cultural events surrounding use of cannabis. Oregon was the first state to decriminalize the possession of small amounts of cannabis, and among the first to authorize its use for medical purposes. An attempt to recriminalize possession of small amounts of cannabis was turned down by Oregon voters in 1997.
In the United States, the use of cannabis for medical purposes is legal in 37 states, four out of five permanently inhabited U.S. territories, and the District of Columbia, as of February 2022. Eleven other states have more restrictive laws limiting THC content, for the purpose of allowing access to products that are rich in cannabidiol (CBD), a non-psychoactive component of cannabis. There is significant variation in medical cannabis laws from state to state, including how it is produced and distributed, how it can be consumed, and what medical conditions it can be used for.
Cannabis in California has been legal for medical use since 1996, and for recreational use since late 2016. The state of California has been at the forefront of efforts to liberalize cannabis laws in the United States, beginning in 1972 with the nation's first ballot initiative attempting to legalize cannabis. Although it was unsuccessful, California would later become the first state to legalize medical cannabis with the passage of the Compassionate Use Act of 1996. In November 2016, California voters approved the Adult Use of Marijuana Act to legalize the recreational use of cannabis.
In the United States, the use and possession of cannabis is illegal under federal law for any purpose by way of the Controlled Substances Act of 1970 (CSA). Under the CSA, cannabis is classified as a Schedule I substance, determined to have a high potential for abuse and no accepted medical use – thereby prohibiting even medical use of the drug. Despite this, most states have legalized either or both the medical and recreational use of cannabis.
Cannabis in Massachusetts is legal for medical and recreational use. It also relates to the legal and cultural events surrounding the use of cannabis. A century after becoming the first U.S. state to criminalize recreational cannabis, Massachusetts voters elected to legalize it in 2016.
Cannabis in Nevada became legal for recreational use on January 1, 2017, following the passage of Question 2 on the 2016 ballot. The first licensed sales of recreational cannabis began on July 1, 2017.
Cannabis in Pennsylvania is illegal for recreational use, but possession of small amounts is decriminalized in several of the state's largest cities. Medical use was legalized in 2016 through a bill passed by the state legislature.
Cannabis in Illinois is legal for both medical and recreational use. Illinois became the eleventh state in the US to legalize recreational marijuana effective January 1, 2020.
Cannabis in New Mexico is legal for recreational use as of June 29, 2021. A bill to legalize recreational use – House Bill 2, the Cannabis Regulation Act – was signed by Governor Michelle Lujan Grisham on April 12, 2021. The first licensed sales of recreational cannabis began on April 1, 2022.
Cannabis in New Jersey is legal for both medical use and recreational use. An amendment to the state constitution legalizing cannabis became effective on January 1, 2021, and enabling legislation and related bills were signed into law by governor Phil Murphy on February 22, 2021.
Cannabis in Maryland is legal for medical use and illegal for recreational use, but as of January 1st, 2023 thru June 30th, 2023, decriminalization is temporarily expanded from possession of less than 1 oz to less than 1.5 oz, prior to full legalized recreational use of 1.5 oz or less on July 1st, 2023 due to the passage of the 2022 Maryland Question 4 referendum. In 2013, a state law was enacted to establish a state-regulated medical cannabis program. The program, known as the Natalie M. LaPrade Maryland Medical Cannabis Commission (MMCC) became operational on December 1, 2017.
Cannabis in Bermuda is legal for medical use and decriminalized for recreational use.
New Jersey Cannabis Regulatory and Expungement Aid Modernization Act (S.2703) is proposed legislation to legalize, tax and regulate adult-use cannabis in the U.S. state of New Jersey, and to expunge certain drug-related offenses. A state Senate–Assembly joint committee passed the bill in November 2018 for a vote by both houses. The state governor Phil Murphy indicated support for legalization in his 2017 campaign.
The Jake Honig Compassionate Use Medical Cannabis Act, nicknamed Jake's Law, was named after 7-year-old Jake Honig who died on January 21, 2018, in New Jersey from brain cancer. Jake's Law expanded the state's medical marijuana program and was based on Jake's story. It was signed into law by Governor Phil Murphy on July 2, 2019.